UC Brain Tumor Center

234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)

All Clinical Studies

AddToAny

Share this
Topic Study No. Clinical Trial Protocol Investigators
Acoustic Neuroma Investigator Initiated A Multicenter Prospective Analysis of Treatment Outcomes in Patients with Large Acoustic Neuromas Receiving Subtotal Resection with Backup Stereotactic Radiation Therapy Theodosopoulos (PI)
Tew
All Tumors (Newly Diagnosed) OBTS Ohio Brain Tumor Study (OBTS) McPherson (PI)
Glioblastoma UCC-R2 Elderly GBM A phase II window study of front-line Axitinib followed by Axitinib and radiation for Elderly patients with Glioblastoma Multiforme (GBM) Rixe (PI)
Glioblastoma UCC-R1 cDNA Development of a Novel Biomarker Utilizing Simultaneous Paired End Sequencing Technique of Tumor Samples and RT PCR for circulating DNA in Glioblastoma Multiforme (GBM) (Temporarily Closed) Rixe (PI)
Glioblastoma RTOG 0837 Randomized, Phase Il, Double-Blind, Placebo-Controlled Trial Of Conventional Chemoradiation And Adjuvant Temozolomide Plus Cediranib Versus Conventional Chemoradiation And Adjuvant Temozolomide Plus Placebo In Patients With Newly Diagnosed Glioblastoma Redmond (PI)
Gliomas NIH 1308 The Cancer Genome Atlas Patient Enrollment and Specimen Qualification Criteria Grade II-IV Gliomas McPherson (PI)
High Grade Gliomas UCBTC-G1 3T versus 1.5T MRI approach in target definition for malignant gliomas: Is there a significant difference in tumor extent and radiation treatment volume? Guarnaschelli (PI)
Low Grade Glioma CTSU E3F05 Phase III Study of Radiation Therapy with or without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas Rixe (PI)
Metastatic Brain Tumor BTC-W1 A Phase II Trial to Evaluate the Use of Trental and Vitamin E for Prophalaxis of Radiation Necrosis Warnick (PI)
Breneman
Recurrent Glioblastoma RTOG 0929 A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma (Temporarily Closed) Redmond (PI)